The Tamiflu (Oseltamivir Phosphate) market comprises anti-viral drugs that are used for the treatment and prevention of influenza. Tamiflu acts by preventing the spread of flu viruses in the body, thus reducing the duration and severity of flu symptoms. It has significant efficacy against influenza A and B viruses and has the advantages of being available in both capsule and suspension forms. The growing burden of influenza across the world is driving the need for effective drugs against flu viruses.

The Global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 25.93 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 To 2031.

Key Takeaways
Key players operating in the Tamiflu (Oseltamivir Phosphate) market are Roche, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mylan N.V., and Sandoz. Roche holds a significant share in the market as Tamiflu is one of its leading products. The growing prevalence of influenza cases globally is the major factor driving the demand for Tamiflu. According to WHO, there are approximately 1 billion cases of flu reported annually worldwide. Technological advancements are allowing the development of medications with increased efficacy, alternatives dosage forms, and new means of preventing influenza transmission.

Market Trends
One of the key Tamiflu (Oseltamivir Phosphate) Market Trends is the development of long-acting formulations. Companies are developing extended-release capsules and injectable forms of Tamiflu to provide protection against flu for longer durations with fewer dosages. Another trend is the introduction of generic and biosimilar versions of Tamiflu which are more affordable. The pricing pressure on innovator drugs due to patent expiries is propelling the growth of generic Tamiflu markets globally.

Get More Insights on- Tamiflu (Oseltamivir Phosphate) Market